Antibiotic resistance (AR), the ability of bacteria to withstand antimicrobial treatments, poses a significant and escalating global health threat.  Driven by the overuse and misuse of antibiotics in human and animal healthcare, and agriculture, AR diminishes the efficacy of existing treatments, leading to prolonged illnesses, increased mortality, and higher healthcare costs.  The global implications are far-reaching, impacting healthcare systems' capacity to manage infectious diseases and potentially jeopardizing progress in various medical fields, including surgery and organ transplantation.

Practical applications to mitigate AR focus on several key strategies.  Firstly, responsible antibiotic stewardship programs are crucial, promoting appropriate prescribing practices and reducing unnecessary antibiotic use.  Secondly, accelerated development and deployment of novel antibiotics and alternative antimicrobial therapies, such as bacteriophages and antimicrobial peptides, are essential.  Thirdly, enhanced surveillance systems are needed to track resistance patterns and inform public health interventions.  Finally, improved hygiene practices, infection control measures, and the development of rapid diagnostic tools contribute to reducing the spread of resistant bacteria.  Addressing AR requires a multi-faceted, global approach encompassing responsible antibiotic use, research and development, and robust public health strategies.  Failure to do so risks a return to a pre-antibiotic era, where common infections could become lethal.